List view / Grid view
19 December 2018 | By Kaiser Optical Systems
The FDA’s Quality by Design (QbD) initiative brought a paradigm shift to pharmaceutical manufacturing and leading manufacturers have realised improved processes after adopting QbD. Raman spectroscopy is an established Process Analytical Technology (PAT), enabling QbD and continuous approaches to pharmaceutical manufacturing.1
19 December 2018 | By Christian Cattaruzza, Dr. Sébastien Ribault, Muriel Richard
For emerging biotech and small companies in early-stage clinical development, accessing the market as quickly as possible is of paramount importance. Biopharma executives must make important decisions at this stage that will impact the success of their commercial strategy. The key to success is making the right decisions at the…
18 December 2018 | By European Pharmaceutical Review
In this supplement: navigating roadblocks to clinical success, and the data challenges of R&D and collaboration.
17 December 2018 | By European Pharmaceutical Review
In this issue: Navigating roadblocks to clinical success: decision-making from molecule to clinic, Raman spectroscopy for the qualitative analysis of falsified and substandard medicines, and an overview of risk assessments for elemental impurities: implementation of ICH Q3D guidelines.
14 December 2018 | By European Pharmaceutical Review
It is paramount that manufacturers and their suppliers ensure that the quality of compounded drugs are high, by preventing risks of contamination...
13 December 2018 | By European Pharmaceutical Review
The FDA has provided guidance on data integrity and compliance; two areas extremely important for pharmaceutical businesses and manufacturers to adhere to...
12 December 2018 | By Kaiser Optical Systems
Raman spectroscopy is an analysis technique that provides a “molecular fingerprint” of the sample, enabling analysis of chemical composition and molecular structure without sample preparation. As a measurement technique, Raman imparts many benefits in applications from laboratory discoveries to feedback-control in manufacturing.
27 November 2018 | By European Pharmaceutical Review
NIST researchers have shown how graphene can be modified with pores and used as an ion filter, and could be adapted for use in drug delivery systems...
26 November 2018 | By Eurofins
Companies often need to arrange for the synthesis of test substances to support research and development efforts.
26 November 2018 | By Eurofins
On 23 June 2016, the decision was made on the European Union referendum for the United Kingdom to withdraw from the European Union.
1 October 2018 | By Iqra Farooq (European Pharmaceutical Review)
Portable biopharmaceutical drug manufacturers could be the future method of producing the drugs on demand for outbreaks of disease...
28 September 2018 | By Mike Stones
The next five years will see game-changing improvements made in upstream, downstream and continuous bioprocessing, predicts one industry specialist...
19 September 2018 | By Iqra Farooq (European Pharmaceutical Review)
Viruses explored through Radiance, an instrument designed to improve the process of analysis, ensures quick and efficient viral detection...
10 September 2018 | By Merck
In this Spotlight on Single Use, David Beattie, Vice President BioProcessing R&D, Merck explains the mode of operation and benefits of its Pellicon® Capsules...
29 August 2018 | By Peak Scientific
Modern laboratories use a number of gases as part of their daily operations. This application note details two of the most common methods of laboratory gas supply, and their associated safety risks and benefits...
Follow: